Clinical trials
Alzheimer Disease or Associated Disorder clinical trials
Below are recruiting alzheimer disease or associated disorder clinical trials, each written for real people, not researchers. We’re tracking 1,805 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07165236Recruiting
Bladder tumor surgery and memory changes study
This study looks at how bladder tumor surgery might affect thinking and memory. It checks blood markers to see if they are linked to any mental changes after the operation.
Osijek, CroatiaAges 18–80 - NCT06942806Recruiting
Spinal cord stimulation for shingles nerve pain
This trial tests a treatment called high-frequency short-time spinal cord stimulation for pain caused by shingles (herpes zoster). It's for people whose pain hasn't improved with other treatments or who can't take pain medicines due to side effects or other health issues.
Zunyi, GuizhouAges 40–85 - NCT07163156Enrolling by invitation
Prolactin and inflammation in Parkinson's severity
This study looks at whether prolactin (a hormone) and inflammation markers in blood and saliva are related to the severity of Parkinson's disease. It may help identify new ways to track the disease.
Çanakkale, MerkezAges 18 years+ - NCT07161102Enrolling by invitation
Foot reflexology for anxiety relief
This study tests whether foot reflexology—a gentle massage on specific points of your feet—can help reduce anxiety. You would attend 10 sessions and your progress would be tracked.
Vitória da Conquista, Estado de BahiaAges 18–80 - NCT07162350Recruiting
Food as medicine for kids with health risks
This study tests whether extra healthy food and nutrition help can improve health in children ages 8-15 who have a high body mass index (BMI). It is for children seen at certain Parkland clinics who have not seen a dietitian in the past year.
Dallas, TexasAges 8–15 - NCT07160205RecruitingPhase 2/Phase 3
Study of ULSC for dermatomyositis and polymyositis
This trial tests a new treatment called ULSC to see if it can improve muscle strength and skin symptoms, and help reduce steroid use in people with dermatomyositis or polymyositis. It may be an option if standard treatments haven't worked well enough.
Gainesville, FloridaAges 18 years+ - NCT07147296Recruiting
Implant to manage blood pressure swings after spinal cord injury
This trial tests an implanted device that may help control drops in blood pressure caused by spinal cord injury. If you often feel dizzy or lightheaded due to low blood pressure, this study could explore whether the device improves stability.
Little Rock, ArkansasAges 18–75 - NCT06318026Recruiting
Personalized alcohol care for primary care patients
This study tests a new way to help people who drink heavily get personalized support for cutting back or quitting. You may qualify if you have had a recent primary care visit and screening shows risky drinking.
Seattle, WashingtonAges 18 years+ - NCT07148843RecruitingPhase 2/Phase 3
CBD for alcohol withdrawal and cravings
This study tests whether adding CBD (a cannabis compound that doesn't get you high) to usual care can help reduce alcohol withdrawal symptoms and cravings. It may offer a new way to support people trying to cut down or stop drinking.
Baltimore, MarylandAges 21–65 - NCT06959147RecruitingPhase 4
Study for nerve pain after shingles using radiofrequency and a numbing shot
This trial tests a two-step procedure for treating nerve pain after shingles (called postherpetic neuralgia). First, a special type of radiofrequency treatment is applied to block the pain signals. Then, a long-lasting numbing medicine is injected under the skin to help keep the pain away. It is for people aged 40 to 85 who have not gotten enough relief from standard medicines.
Zunyi, GuizhouAges 40–85 - NCT07144462RecruitingEarly Phase 1
Testing a new drug for people with certain autoimmune diseases that have come back or not responded to treatment
This trial is testing a new injection, NEUK203-215, in adults aged 18-65 with certain autoimmune diseases (like lupus, scleroderma, inflammatory myopathy, or a skin blistering condition) that have relapsed or not responded to standard therapy. The goal is to see if it is safe, tolerable, and may help control the disease.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07137338RecruitingPhase 1
Gene therapy for BAG3-related dilated cardiomyopathy
This trial tests a one-time gene therapy called RP-A701 for people with dilated cardiomyopathy caused by a BAG3 gene mutation. The goal is to see if it is safe and can improve heart function.
San Diego, CaliforniaAges 18–65 - NCT07137949Recruiting
Music therapy to prevent delirium in patients with memory or movement problems
This trial tests whether a music therapy session can help prevent delirium (sudden confusion) in hospitalized patients with memory or movement disorders like Parkinson's or Alzheimer's. If it works, music could become a drug-free way to keep you clearer-headed during a hospital stay.
Boston, MassachusettsAges 60 years+ - NCT07134335RecruitingPhase 2
Study of UBT251 injection for chronic kidney disease
This study tests an investigational injection called UBT251 for people with chronic kidney disease who are overweight. It aims to see if it can reduce protein in the urine and help protect kidney function.
BeijingAges 18–75 - NCT07127224Recruiting
Predicting recovery with smell tests in coma
This study tests whether a simple smell test can help predict recovery of consciousness in patients who remain in a coma or minimally conscious state after a severe brain injury. If you or your loved one has been unresponsive for several days after sedation is stopped, this trial may provide useful information about prognosis.
Paris, GHU Psychiatrie Et NeurosciencesAges 18 years+ - NCT07129174Recruiting
Lung bacteria changes in neurosurgery ICU patients with breathing tubes
This study looks at how tiny organisms in the lungs (the lung microbiome) change in neurosurgery patients who need a breathing tube in the ICU. It aims to see if these changes affect recovery or outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07122401RecruitingPhase 3
Study of MT1013 for dialysis patients with high parathyroid hormone
This trial tests a new medicine called MT1013 for people with secondary hyperparathyroidism who are on dialysis. It may help control high parathyroid hormone levels when current treatments are not enough.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07125534Recruiting
Alcohol and social interaction brain study
This study looks at how drinking alcohol affects brain activity during social interactions. You will be asked to visit the lab, consume a measured amount of alcohol, and have your brain activity recorded while talking or interacting with others. It aims to help understand social brain function.
Champaign, IllinoisAges 21–30 - NCT07120880RecruitingPhase 3
Light therapy timing for depression with insomnia
This trial tests whether giving light therapy at a specific time of day can improve both depression and sleep problems. It is for adults with major depression and insomnia who are not currently on antidepressants.
ParisAges 18–65 - NCT07120061Recruiting
Test-retest reliability of the wakefulness test in sleepy participants
This study is testing how reliable a test called the Maintenance of Wakefulness Test (MWT) is for measuring daytime sleepiness. It looks at different groups: people with sleep apnea, people with narcolepsy, and healthy volunteers. The goal is to see if the MWT gives consistent results when repeated.
BordeauxAges 18–65 - NCT07107659RecruitingEarly Phase 1
Testing ONT01 for active lupus
This trial tests a new drug called ONT01 for people with active lupus that is not affecting their kidneys. It is for those who have not had success with standard treatments.
New York, New YorkAges 18 years+ - NCT07100782RecruitingPhase 3
Estrogen & pain trial for endometriosis pelvic pain
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
Ann Arbor, MichiganAges 18–49 - NCT07105865Recruiting
Nickel and LTPs in stomach and bowel issues
This study looks at whether being sensitive to nickel or certain proteins called LTPs is linked to ongoing stomach and bowel problems. It aims to find better ways to diagnose and help people with functional dyspepsia or irritable bowel syndrome.
Naples, NaplesAges 4–65 - NCT07102966Recruiting
Genetic study for babies with birth defects in Texas
This study looks for genetic causes of birth defects in newborn babies. If your baby has a suspected genetic condition and other tests haven't found a clear cause, this study may help find answers.
Houston, TexasAges 1 day–3 months
Hear when a new Alzheimer Disease or Associated Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer disease or associated disorder?
- Yes. Clin2 currently lists 1,805 recruiting alzheimer disease or associated disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer disease or associated disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer disease or associated disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.